Persistence of Igg and Neutralizing Antibodies in Crimean−Congo Hemorrhagic Fever Survivors Publisher Pubmed



Vasmehjani AA¹ ; Pouriayevali MH² ; Shahmahmoodi S^{1, 3} ; Salehivaziri M^{2, 4} Show Affiliations
Source: Journal of Medical Virology Published:2024

Abstract

The World Health Organization classified Crimean–Congo hemorrhagic fever (CCHF) as a high-priority infectious disease and emphasized the performance of research studies and product development against it. Little information is available about the immune response due to natural CCHF virus (CCHFV) infection in humans. Here, we investigated the persistence of IgG and neutralizing antibodies in serum samples collected from 61 Iranian CCHF survivors with various time points after recovery (<12, 12−60, and >60 months after disease). The ELISA results showed IgG seropositivity in all samples while a pseudotyped based neutralization assay findings revealed the presence of neutralizing antibody in 29 samples (46.77%). For both IgG and neutralizing antibodies, a decreasing trend of titer was observed with the increase in the time after recovery. Not only the mean titer of IgG (772.80 U/mL) was higher than mean neutralizing antibody (25.64) but also the IgG persistence was longer. In conclusion, our findings provide valuable information about the long-term persistence of humoral immune response in CCHF survivors indicating that IgG antibody can be detected at least 8 years after recovery and low titers of neutralizing antibody can be detected in CCHF survivors. © 2024 Wiley Periodicals LLC.